These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 33886161)
1. The impact of donor-specific anti-human leukocyte antigen antibodies in salvage haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide in patients with nonmalignant disorders. Lima ACM; Bonfim C; Getz J; Dornelles LN; do Amaral GB; Petterle RR; Loth G; Nabhan SK; Pereira NF; Pasquini R HLA; 2021 Jun; 97(6):493-504. PubMed ID: 33886161 [TBL] [Abstract][Full Text] [Related]
2. Untreated Donor-Specific HLA Antibodies Are Associated With Graft Failure and Poor Survival After Haploidentical Transplantation With Post-Transplantation Cyclophosphamide in Pediatric Patients With Nonmalignant Disorders. Lima ACM; Bonfim C; Getz J; do Amaral GB; Petterle RR; Loth G; Nabhan SK; de Marco R; Gerbase-DeLima M; Pereira NF; Pasquini R Transplant Cell Ther; 2022 Oct; 28(10):698.e1-698.e11. PubMed ID: 35882362 [TBL] [Abstract][Full Text] [Related]
3. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy. Bailén R; Alenda R; Herruzo-Delgado B; Acosta-Fleitas C; Vallés A; Esquirol A; Fonseca M; Solán L; Sánchez-Vadillo I; Bautista G; Bento L; López-Godino O; Pérez-Martínez A; Torrent A; Zanabili J; Calbacho M; Moreno MÁ; Pascual-Cascón MJ; Guerra-Domínguez L; Chinea A; García-Cadenas I; López-Corral L; Boix-Giner F; López Lorenzo JL; Humala K; Duarte R; Sampol A; Heras I; Vicario JL; Balas A; Oarbeascoa G; Fernández-Caldas P; Anguita J; Kwon M Front Immunol; 2023; 14():1165759. PubMed ID: 37304258 [TBL] [Abstract][Full Text] [Related]
4. Donor-Specific HLA Antibodies Are Associated with Graft Failure and Delayed Hematologic Recovery after Unrelated Donor Hematopoietic Cell Transplantation. Lima ACM; Getz J; do Amaral GB; Loth G; Funke VAM; Nabhan SK; Petterle RR; de Marco R; Gerbase-DeLima M; Pereira NF; Bonfim C; Pasquini R Transplant Cell Ther; 2023 Aug; 29(8):493.e1-493.e10. PubMed ID: 37220839 [TBL] [Abstract][Full Text] [Related]
5. Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets. Chang YJ; Zhao XY; Xu LP; Zhang XH; Wang Y; Han W; Chen H; Wang FR; Mo XD; Zhang YY; Huo MR; Zhao XS; Y K; Liu KY; Huang XJ J Hematol Oncol; 2015 Jul; 8():84. PubMed ID: 26156584 [TBL] [Abstract][Full Text] [Related]
6. Donor-Specific Anti-HLA Antibodies in Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: Risk of Graft Failure, Poor Graft Function, and Impact on Outcomes. Bramanti S; Calafiore V; Longhi E; Mariotti J; Crespiatico L; Sarina B; De Philippis C; Nocco A; Santoro A; Castagna L Biol Blood Marrow Transplant; 2019 Jul; 25(7):1395-1406. PubMed ID: 30826463 [TBL] [Abstract][Full Text] [Related]
7. Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant. Bailén R; Vicario JL; Solán L; Sánchez-Vadillo I; Herrera P; Calbacho M; Alenda R; López-Lorenzo JL; Humala K; Chinea A; Sánchez-Pina J; Balas A; Moreno MÁ; Arzuaga J; Pradillo V; Dorado N; Oarbeascoa G; Anguita J; Díez-Martín JL; Kwon M Front Immunol; 2021; 12():674658. PubMed ID: 34093576 [TBL] [Abstract][Full Text] [Related]
8. [Impact of immunosuppression intensified conditioning regimen for patients with strong positive pre-transplantation donor-specific anti-HLA antibodies (DSAs) undergoing haploidentical hematopoietic stem cell transplantation]. Liu HX; Wei DL; Shao S; Jiang Y; Li S; Zhu J; Wang C; Zhao CX Zhonghua Xue Ye Xue Za Zhi; 2023 Aug; 44(8):654-659. PubMed ID: 37803839 [No Abstract] [Full Text] [Related]